Quick Answer
Orthofix Medical Inc. reported Diluted EPS of $2.33 per share (loss) for fiscal year 2025.
Orthofix Medical Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.33 | +29.4% |
| 2024 | -$3.30 | +19.9% |
| 2023 | -$4.12 | -320.4% |
| 2022 | -$0.98 | +49.7% |
| 2021 | -$1.95 | -1600.0% |
| 2020 | $0.13 | +108.6% |
| 2019 | -$1.51 | -309.7% |
| 2018 | $0.72 | +111.8% |
| 2017 | $0.34 | +100.0% |
| 2016 | $0.17 | +213.3% |
| 2015 | -$0.15 | +67.4% |
| 2014 | -$0.46 | +70.1% |
| 2013 | -$1.54 | -169.7% |
| 2012 | $2.21 | +323.2% |
| 2011 | -$0.99 | -140.1% |
| 2010 | $2.47 | +73.9% |
| 2009 | $1.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.57 | +19.7% | -58.3% |
| June 30, 2025 | -$0.36 | +59.1% | +73.3% |
| March 31, 2025 | -$1.35 | -42.1% | -90.1% |
| September 30, 2024 | -$0.71 | +7.8% | +19.3% |
| June 30, 2024 | -$0.88 | +17.8% | +7.4% |
| March 31, 2024 | -$0.95 | +44.4% | -23.4% |
| September 30, 2023 | -$0.77 | -45.3% | +28.0% |
| June 30, 2023 | -$1.07 | -991.7% | +37.4% |
- Orthofix Medical Inc. showed an increase of +29.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, Orthofix Medical Inc.’s diluted eps has declined by 264.1% (from $1.42 per share to $2.33 per share (loss)).
- The most recent figure is from Orthofix Medical Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: